The FDA must maintain a delicate balance: being a model of openness regarding the scientific basis of its decisions, while safeguarding the proprietary secrets of the industries it regulates as well as personal data.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/xWEgzZk
No comments:
Post a Comment